These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7559953)

  • 1. Use of a 24-kilodalton Trypanosoma cruzi recombinant protein to monitor cure of human Chagas' disease.
    Krautz GM; Galvão LM; Cançado JR; Guevara-Espinoza A; Ouaissi A; Krettli AU
    J Clin Microbiol; 1995 Aug; 33(8):2086-90. PubMed ID: 7559953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of antibodies in sera from Chagas' disease patients using a Trypanosoma cruzi immunodominant recombinant antigen.
    Paranhos-Bacalla GS; Santos MR; Cotrim PC; Rassi A; Jolivet M; Camargo ME; Da Silveira JF
    Parasite Immunol; 1994 Mar; 16(3):165-9. PubMed ID: 8208589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological and structural characterization of an epitope from the Trypanosoma cruzi KMP-11 protein.
    Díez H; Guzmán F; Alba MP; Cuéllar A; Thomas MC; López MC; Rosas F; Velasco V; González JM; Patarroyo ME; Puerta CJ
    Peptides; 2007 Aug; 28(8):1520-6. PubMed ID: 17683828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a recombinant Trypanosoma cruzi protein antigen to monitor cure of Chagas disease.
    Guevara AG; Taibi A; Alava J; Guderian RH; Ouaissi A
    Trans R Soc Trop Med Hyg; 1995; 89(4):447-8. PubMed ID: 7570896
    [No Abstract]   [Full Text] [Related]  

  • 5. Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' disease.
    Martins-Filho OA; Pereira ME; Carvalho JF; Cançado JR; Brener Z
    Clin Diagn Lab Immunol; 1995 Sep; 2(5):569-73. PubMed ID: 8548536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Soluble antigens released by Trypanosoma cruzi trypomastigotes used in ELISA to detect cure in chagasic patients following specific treatment].
    Krautz GM; Coutinho MG; Galvão LM; Cançado JR; Krettli AU
    Rev Soc Bras Med Trop; 1994; 27(4):199-207. PubMed ID: 7531867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Trypanosoma cruzi purified glycoprotein (GP57/51) or trypomastigote-shed antigens to assess cure for human Chagas' disease.
    Gazzinelli RT; Galvao LM; Krautz G; Lima PC; Cancado JR; Scharfstein J; Krettli AU
    Am J Trop Med Hyg; 1993 Nov; 49(5):625-35. PubMed ID: 8250103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human antibody responses to Trypanosoma cruzi 70-kD heat-shock proteins.
    Krautz GM; Peterson JD; Godsel LM; Krettli AU; Engman DM
    Am J Trop Med Hyg; 1998 Feb; 58(2):137-43. PubMed ID: 9502594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Trypanosoma cruzi and anti-laminin antibodies in chagasic patients after specific treatment.
    Gazzinelli RT; Galvão LM; Cardoso JE; Cançado JR; Krettli AU; Brener Z; Gazzinelli G
    J Clin Microbiol; 1988 Sep; 26(9):1795-800. PubMed ID: 3141467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of anti-trypomastigote lytic antibodies for determining cure of Trypanosoma cruzi infections in treated patients: an overview and perspectives.
    Krettli AU
    Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():142-51. PubMed ID: 19753469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardization of micro-enzyme-linked immunosorbent assay (ELISA) and Western blot for detection of Trypanosoma cruzi antibodies using extracts from Mexican strains as antigens.
    Sánchez B; Monteón V; Reyes PA; Espinoza B
    Arch Med Res; 2001; 32(5):382-8. PubMed ID: 11578752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of chagasic and non-chagasic myocardiopathies by ELISA and immunoblotting with antigens of Trypanosoma cruzi and Trypanosoma rangeli.
    O'Daly JA; Carrasco H; Fernandez V; Rodríguez MB
    Acta Trop; 1994 Apr; 56(4):265-87. PubMed ID: 8023751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide screening and identification of new Trypanosoma cruzi antigens with potential application for chronic Chagas disease diagnosis.
    Reis-Cunha JL; Mendes TA; de Almeida Lourdes R; Ribeiro DR; Machado-de-Avila RA; de Oliveira Tavares M; Lemos DS; Câmara AC; Olórtegui CC; de Lana M; da Cunha Galvão LM; Fujiwara RT; Bartholomeu DC
    PLoS One; 2014; 9(9):e106304. PubMed ID: 25225853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High specificity of Trypanosoma cruzi epimastigote ribonucleoprotein as antigen in serodiagnosis of Chagas' disease.
    Solana ME; Katzin AM; Umezawa ES; Miatello CS
    J Clin Microbiol; 1995 Jun; 33(6):1456-60. PubMed ID: 7650167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of recombinant flagellar calcium-binding protein for serodiagnosis of Trypanosoma cruzi infection.
    Godsel LM; Tibbetts RS; Olson CL; Chaudoir BM; Engman DM
    J Clin Microbiol; 1995 Aug; 33(8):2082-5. PubMed ID: 7559952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.
    Caballero ZC; Sousa OE; Marques WP; Saez-Alquezar A; Umezawa ES
    Clin Vaccine Immunol; 2007 Aug; 14(8):1045-9. PubMed ID: 17522327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and partial characterization of a 28 kDa antigenic protein of Trypanosoma cruzi.
    Abate T; Rosenberg M; Aldao RR; Slezynger TC
    Biol Res; 1993; 26(1-2):121-30. PubMed ID: 7670524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
    Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
    PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPI-anchored glycoconjugates from Trypanosoma cruzi trypomastigotes are recognized by lytic anti-alpha-galactosyl antibodies isolated from patients with chronic Chagas' disease.
    Almeida IC; Ferguson MA; Schenkman S; Travassos LR
    Braz J Med Biol Res; 1994 Feb; 27(2):443-7. PubMed ID: 8081263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune response to the Trypanosoma cruzi complement regulatory protein as an indicator of parasitologic clearance in human Chagas' disease.
    Norris KA; Galvão LM; Schrimpf JE; Cançado JR; Krettli AU
    Infect Immun; 1994 Sep; 62(9):4072-4. PubMed ID: 8063427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.